Pulmonary veno-occulsive disease

S107 Genotype-phenotype associations in pulmonary arterial hypertension caused by BMPR2 and EIF2AK4 variants
C Hadinnapola, M Haimel, M Bleda, H Bogaard, G Coghlan, P Corris, S Gibbs, D Kiely, A Lawrie, A Peacock, J Pepke-Zaba, L Southgate, M Toshner, R Trembath, A Vonk Noordegraaf, J Wharton, M Wilkins, SJ Wort, S Graf, NM Morrell

Thorax Dec 2016, 71 (Suppl 3) A63-A64; DOI: 10.1136/thoraxjnl-2016-209333.113
S83 Investigating the role of GCN2 in the pathogenesis of pulmonary hypertension
E Soon, A Crosby, M Southwood, S Moore, D Ron, S Marciniak, NW Morrell

Thorax Dec 2016, 71 (Suppl 3) A48; DOI: 10.1136/thoraxjnl-2016-209333.89
S86 Understanding the role of GCN2 in modulating BMP signaling using drosophila – implications for pulmonary hypertension
E Malzer, CS Dominicus, SJ Marciniak

Thorax Dec 2016, 71 (Suppl 3) A49-A50; DOI: 10.1136/thoraxjnl-2016-209333.92
Acute respiratory distress syndrome or pulmonary oedema?
Yi-Ting Chen, Wei-Kai Wu, Yung-Hsiang Hsu

Thorax May 2015, 70 (5) 511; DOI: 10.1136/thoraxjnl-2015-206806
S100 The bone morphogenetic protein type II receptor is critical for venous angiogenesis in zebrafish
J E Cannon, C R Bradshaw, J C Smith, N W Morrell

Thorax Dec 2011, 66 (Suppl 4) A47; DOI: 10.1136/thoraxjnl-2011-201054b.100
Pulmonary veno-occlusive disease presenting with recurrent pulmonary oedema and the use of nitric oxide to predict response to sildenafil
B C Creagh-Brown, A G Nicholson, R Showkathali, J S R Gibbs, L S G E Howard

Thorax Oct 2008, 63 (10) 933-934; DOI: 10.1136/thx.2007.088831
Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis
H Nunes, M Humbert, F Capron, M Brauner, O Sitbon, J-P Battesti, G Simonneau, D Valeyre

Thorax Jan 2006, 61 (1) 68-74; DOI: 10.1136/thx.2005.042838

Log in using your username and password

Main menu

Log in using your username and password

You are here

Pulmonary veno-occulsive disease